Jayati Vaidya

Program Leader, Alpha-1 Antitrypsin Deficiency (aatd) at Korro Bio

Jayati Vaidya has a wealth of experience in the life sciences industry. Jayati began their career in 2010 as a Regulatory Scientist at Voisin Consulting Life Sciences. In 2012, they moved to Deloitte where they worked as a Senior Consultant in the Life Sciences division. In 2015, they joined Slalom Consulting as a Life Sciences Strategic Advisor. In 2017, they became a Managing Consultant in Life Sciences Strategy at Navigant. From 2019 to 2022, they worked at Vertex Pharmaceuticals in various roles, including Director of US Cystic Fibrosis Sales Rotation, Director of Global Pipeline Marketing for Hemoglobinopathy (Sickle Cell and Beta Thalassemia) Program, and Director of Global Pipeline Marketing for Pain Program. Currently, they are a Senior Director of Strategy and Portfolio Planning at Korro Bio, Inc.

Jayati Vaidya is currently enrolled at the Massachusetts College of Pharmacy and Health Sciences.

Links

Previous companies

Deloitte logo
Vertex Pharmaceuticals logo

Org chart

Peers

Timeline

  • Program Leader, Alpha-1 Antitrypsin Deficiency (aatd)

    January 1, 2024 - present

  • Senior Director, Corporate Strategy And Portfolio Planning

    May, 2022

View in org chart